Rita R. Alloway

8.7k total citations
227 papers, 6.2k citations indexed

About

Rita R. Alloway is a scholar working on Transplantation, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Rita R. Alloway has authored 227 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 157 papers in Transplantation, 80 papers in Surgery and 41 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Rita R. Alloway's work include Renal Transplantation Outcomes and Treatments (150 papers), Organ Transplantation Techniques and Outcomes (55 papers) and Pharmacological Effects and Toxicity Studies (32 papers). Rita R. Alloway is often cited by papers focused on Renal Transplantation Outcomes and Treatments (150 papers), Organ Transplantation Techniques and Outcomes (55 papers) and Pharmacological Effects and Toxicity Studies (32 papers). Rita R. Alloway collaborates with scholars based in United States, United Kingdom and Canada. Rita R. Alloway's co-authors include E. Steve Woodle, A. Osama Gaber, M. Roy First, Joseph F. Buell, Prabir Roy‐Chaudhury, Robert J. Stratta, Jennifer Trofe, Michael J. Hanaway, Michael Cardi and J Everly and has published in prestigious journals such as Journal of Clinical Investigation, Annals of Surgery and Kidney International.

In The Last Decade

Rita R. Alloway

221 papers receiving 6.0k citations

Peers

Countries citing papers authored by Rita R. Alloway

Since Specialization

Citations

This map shows the geographic impact of Rita R. Alloway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita R. Alloway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita R. Alloway more than expected).

Fields of papers citing papers by Rita R. Alloway

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita R. Alloway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita R. Alloway. The network helps show where Rita R. Alloway may publish in the future.

Co-authorship network of co-authors of Rita R. Alloway

This figure shows the co-authorship network connecting the top 25 collaborators of Rita R. Alloway. A scholar is included among the top collaborators of Rita R. Alloway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita R. Alloway. Rita R. Alloway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Use of LCP-Tacrolimus (LCPT) in Kidney Transplantation: A Delphi Consensus Survey of Expert Clinicians 2024 ·Annals of Transplantation ·Alexander C. Wiseman, Tarek Alhamad, Rita R. Alloway, Beatrice P. Concepcion, Matthew Cooper, Richard N. Formica, Christina L. Klein, Vineeta Kumar, Nicolae Leca, Fuad S. Shihab, David J. Taber, (unknown), Donald M. Bushnell, (unknown), Suphamai Bunnapradist	1
2	Early initiation of glecaprevir/pibrentasvir after transplantation of HCV‐viremic kidneys into HCV‐negative recipients is associated with normalization in the altered inflammatory milieu 2023 ·Clinical Transplantation ·(unknown), Meghan E. Sise, Min Xu, David S. Goldberg, Robert J. Fontana, Jens Kort, Rita R. Alloway, Christine M. Durand, Robert S. Brown, Josh Levitsky, Jenna Gustafson, Peter P. Reese, Raymond T. Chung	0
3	Belatacept for Simultaneous Calcineurin Inhibitor and Chronic Corticosteroid Immunosuppression Avoidance 2021 ·Clinical Journal of the American Society of Nephrology ·Dixon B. Kaufman, E. Steve Woodle, Adele R. Shields, John P. Leone, Arthur J. Matas, Alexander C. Wiseman, Patricia West‐Thielke, (unknown), Eileen King, Rita R. Alloway, (unknown)	26
4	Incorporating Patients’ Values and Preferences Into Decision Making About Transplantation of HCV-Naïve Recipients With Kidneys From HCV-Viremic Donors: A Feasibility Study 2021 ·MDM Policy & Practice ·Mark H. Eckman, (unknown), Heather J. Duncan, E. Steve Woodle, Charuhas V. Thakar, Rita R. Alloway, Kenneth E. Sherman	1
5	Belatacept-based immunosuppression with simultaneous calcineurin inhibitor avoidance and early corticosteroid withdrawal: A prospective, randomized multicenter trial 2019 ·American Journal of Transplantation ·E. Steve Woodle, Dixon B. Kaufman, Adele R. Shields, John P. Leone, Arthur J. Matas, Alexander C. Wiseman, Patricia West‐Thielke, (unknown), Eileen King, Rita R. Alloway	48
6	Assessment of tacrolimus intrapatient variability in stable adherent transplant recipients: Establishing baseline values 2018 ·American Journal of Transplantation ·Abbie D. Leino, Eileen King, Wenlei Jiang, Alexander A. Vinks, Jost Klawitter, Uwe Christians, E. Steve Woodle, Rita R. Alloway, Jennifer Rohan	83
7	Contrast-Induced Nephropathy in Renal Transplant Recipients: A Single Center Experience 2017 ·Frontiers in Medicine ·Bassam G. Abu Jawdeh, Anthony C. Leonard, (unknown), (unknown), Adele R. Shields, Rita R. Alloway, E. Steve Woodle, Charuhas V. Thakar	9
8	Review of Bortezomib Treatment of Antibody-Mediated Rejection in Renal Transplantation 2014 ·Antioxidants and Redox Signaling ·(unknown), Rita R. Alloway, Fabian Halleck, Michael Dürr, Klemens Budde, E. Steve Woodle	35
9	Proteasome inhibitor-based therapy for antibody-mediated rejection 2012 ·Kidney International ·R. C. Walsh, Rita R. Alloway, Alin Girnita, E. Steve Woodle	72
10	Clinical and investigational use of proteasome inhibitors for transplant rejection 2011 ·Expert Opinion on Investigational Drugs ·Basma Sadaka, Rita R. Alloway, E. Steve Woodle	10
11	Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end‐stage renal disease and transplant patients: a pilot study 2007 ·Clinical Transplantation ·Christin C. Rogers, Rita R. Alloway, J. Wesley Alexander, Michael Cardi, Jennifer Trofe, Alexander A. Vinks	150
12	Once-Daily Tacrolimus Extended Release Formulation: Experience at 2 Years Postconversion From a Prograf-Based Regimen in Stable Liver Transplant Recipients 2007 ·Transplantation ·Sander Florman, Rita R. Alloway, Münci Kalayoğlu, Jeffrey D. Punch, Thomas H. Bak, J. Keith Melancon, (unknown), Stéphan Busque, Michael Charlton, John R. Lake, Shobha Dhadda, (unknown), Mary J. Wirth, William E. Fitzsimmons, John Holman, M. Roy First	42
13	Risk Assessment of Immunosuppressive Therapy in Facial Transplantation 2007 ·Plastic & Reconstructive Surgery ·Dalibor Vasilic, Rita R. Alloway, John H. Barker, Allen Furr, (unknown), Joseph C. Banis, Moshe Kon, E. Steve Woodle	35
14	Risk Factors and Outcomes Analyses at 36 Months of a Prospective, Randomized, Multicenter, Trial of Daclizumab Induction in Simultaneous Kidney–Pancreas Transplant Recipients 2005 ·Transplantation Proceedings ·Robert J. Stratta, Rita R. Alloway, A Lo, E Hodge	4
15	Donor Kidneys With Small Renal Cell Cancers: Can They Be Transplanted? 2005 ·Transplantation Proceedings ·Joseph F. Buell, Michael J. Hanaway, Mark Thomas, R Munda, Rita R. Alloway, M. Roy First, E. Steve Woodle	45
16	The importance of early prevention of renal dysfunction in liver transplant recipients 2001 ·Transplantation Proceedings ·Hosein Shokouh‐Amiri, Maria Francesca Egidi, A Lo, Hani P. Grewal, Santiago Vera, Robert J. Stratta, (unknown), (unknown), J Trofe, Rita R. Alloway, P A Cowan, A. Osama Gaber	6
17	Renal allograft outcomes in African American versus Caucasian transplant recipients in the tacrolimus era 2001 ·Surgery ·Karen L. Hardinger, Robert J. Stratta, Maria Francesca Egidi, Rita R. Alloway, Hosein Shokouh‐Amiri, Lillian W. Gaber, Hani P. Grewal, (unknown), Santiago Vera, A. Osama Gaber	21
18	Renal histology with varying FK506 blood levels 1997 ·Transplantation Proceedings ·Lillian W. Gaber, Linda W. Moore, (unknown), (unknown), Rita R. Alloway, Donna Hathaway, Hosein Shokouh‐Amiri, A. Osama Gaber	8
19	CLINICAL OBSERVATIONS OF METABOLIC CHANGES OCCURRING IN RENAL TRANSPLANT RECIPIENTS RECEIVING KETOCONAZOLE 1996 ·Transplantation ·Linda W. Moore, Rita R. Alloway, Sergio R. Acchiardo, Santiago Vera, (unknown), A. Osama Gaber	24
20	Prevention of hepatitis B recurrence with indefinite hepatitis B immune globulin (HBIG) prophylaxis after liver transplantation 1996 ·Clinical Transplantation ·(unknown), Hosein Shokouh‐Amiri, Santiago Vera, Caroline A. Riely, Rita R. Alloway, A. Osama Gaber	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact